- Home
- CSGS vs BHVN Comparison
CSGS vs BHVN Comparison
Compare CSGS & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSGS
- BHVN
- Stock Information
- Founded
- CSGS 1994
- BHVN 2013
- Country
- CSGS United States
- BHVN United States
- Employees
- CSGS N/A
- BHVN N/A
- Industry
- CSGS EDP Services
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- CSGS Technology
- BHVN Health Care
- Exchange
- CSGS Nasdaq
- BHVN Nasdaq
- Market Cap
- CSGS 1.9B
- BHVN 1.9B
- IPO Year
- CSGS 1996
- BHVN 2017
- Fundamental
- Price
- CSGS $78.68
- BHVN $18.11
- Analyst Decision
- CSGS Buy
- BHVN Strong Buy
- Analyst Count
- CSGS 9
- BHVN 14
- Target Price
- CSGS $69.71
- BHVN $49.23
- AVG Volume (30 Days)
- CSGS 291.3K
- BHVN 2.2M
- Earning Date
- CSGS 11-05-2025
- BHVN 11-11-2025
- Dividend Yield
- CSGS 1.86%
- BHVN N/A
- EPS Growth
- CSGS 30.24
- BHVN N/A
- EPS
- CSGS 2.89
- BHVN N/A
- Revenue
- CSGS $1,208,376,000.00
- BHVN N/A
- Revenue This Year
- CSGS $4.74
- BHVN N/A
- Revenue Next Year
- CSGS $3.19
- BHVN $2,079.03
- P/E Ratio
- CSGS $27.25
- BHVN N/A
- Revenue Growth
- CSGS 3.31
- BHVN N/A
- 52 Week Low
- CSGS $46.17
- BHVN $12.79
- 52 Week High
- CSGS $79.20
- BHVN $54.98
- Technical
- Relative Strength Index (RSI)
- CSGS 86.21
- BHVN 60.97
- Support Level
- CSGS $63.70
- BHVN $16.30
- Resistance Level
- CSGS $68.28
- BHVN $17.83
- Average True Range (ATR)
- CSGS 1.23
- BHVN 1.23
- MACD
- CSGS 1.06
- BHVN 0.08
- Stochastic Oscillator
- CSGS 96.81
- BHVN 91.88
About CSGS CSG Systems International Inc.
CSG Systems International Inc is a purpose-driven, SaaS platform company that enables companies in a wide variety of industry verticals to tackle the growing complexity of business in the digital age. The company's cloud-first architecture and customer-centric approach empower companies to deliver unforgettable experiences for B2B (business-to-business), B2C (business-to-consumer), and B2B2X (business-to-business-to-consumer) customers, making it easier for people and businesses to connect to, use and pay for the services the company offers. The company operates in one segment i.e. Solutions and Services. Geographically, the company generates revenue from the United States.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.